Northern Trust Corp grew its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 7.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 245,110 shares of the company's stock after acquiring an additional 16,421 shares during the quarter. Northern Trust Corp owned about 0.61% of Phibro Animal Health worth $5,147,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of PAHC. Aquatic Capital Management LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at $69,000. Quantbot Technologies LP boosted its holdings in shares of Phibro Animal Health by 65.1% during the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after acquiring an additional 2,018 shares during the period. Meeder Asset Management Inc. acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at $113,000. New York State Teachers Retirement System raised its stake in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares in the last quarter. Finally, Nebula Research & Development LLC bought a new stake in Phibro Animal Health in the fourth quarter worth about $210,000. Institutional investors and hedge funds own 99.34% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on the stock. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Finally, Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $20.00.
Read Our Latest Report on Phibro Animal Health
Phibro Animal Health Trading Up 1.0%
NASDAQ PAHC traded up $0.22 on Friday, hitting $23.24. 135,439 shares of the company were exchanged, compared to its average volume of 199,023. The company's 50 day moving average price is $20.29 and its 200-day moving average price is $21.88. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The firm has a market capitalization of $942.01 million, a P/E ratio of 48.42, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 annualized dividend and a yield of 2.07%. Phibro Animal Health's payout ratio is presently 61.54%.
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.